Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine

Infection and Immunity

Volumn 73, Issue 4, 2005, Pages 2360-2366

  Kotloff, Karen L ^a   Wasserman, Steven S ^a   Jones, Kevin F ^b   Livio, Sofie ^a   Hruby, Dennis E ^b   Franke, Christine A ^b   Fischetti, Vincent A ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SIGA Technologies Incorporated   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL ANTIGEN; FLOXURIDINE; STREPTOCOCCUS VACCINE; STREPTOMYCIN; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; RECOMBINANT VACCINE; STREPTOCOCCAL M PROTEIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; DISEASE COURSE; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS GORDONII; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME; ADOLESCENT; CLINICAL TRIAL; DRUG EFFECT; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; AZITHROMYCIN; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; HUMANS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; VACCINES, SYNTHETIC;

EID: 16244365147     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.4.2360-2366.2005     Document Type: Article

References (36)

1. Beninati, C., M. R. Oggioni, M. Boccanera, M. R. Spinosa, T. Maggi, S. Conti, W. Magliani, F. De Bernardis, G. Teti, A. Cassone, G. Pozzi, and L. Polonelli. 2000. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat. Biotechnol. 18:1060-1064.
2. Bolken, T. C., C. A. Franke, K. F. Jones, R. H. Bell, R. M. Swanson, D. S. King, V. A. Fischetti, and D. E. Hruby. 2002. Analysis of factors affecting surface expression and immunogenicity of recombinant proteins expressed by gram-positive commensal vectors. Infect. Immun. 70:2487-2491.
3. Byrd, C. M., T. C. Bolken, K. F. Jones, T. K. Warren, A. T. Vella, J. McDonald, D. King, Z. Blackwood, and D. E. Hruby. 2002. Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors. Vaccine 20:2197-2205.
4. Catanzaro, F. J., C. A. Stetson, A. J. Morris, R. Chamovitz, J. C. H. Rammelkamp, B. L. Stolzer, and W. D. Perry. 1954. The role of streptococcus in the pathogenesis of rheumatic fever. Am. J. Med. 17:749-756.
5. Cole, M. F., S. P. Fitzsimmons, M. J. Sheridan, and Y. Xu. 1995. Humoral immunity to commensal oral bacteria: quantitation, specificity and avidity of serum IgG and IgM antibodies reactive with Actinobacillus actinomycetem-comitans in children. Microbiol. Immunol. 39:591-598.
6. D'Alessandri, R., G. Plotkin, R. M. Kluge, M. K. Winner, E. N. Fox, A. Dorfman, and R. H. Waldman. 1978. Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with Type 3 or Type 12 group A Streptococcus. J. Infect. Dis. 138:712-718.
7. Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewe, and K. H. Meyer zum Buschenfelde. 1995. Tolerance exists toward resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102:448-455.
8. Fischetti, V. A. 1991. Streptococcal M protein. Sci. Am. 264:58-65.
9. Fitzsimmons, S., M. Evans, C. Pearce, M. J. Sheridan, R. Wientzen, G. Bowden, and M. F. Cole. 1996. Clonal diversity of Streptococcus milis biovar 1 isolates from the oral cavity of human neonates. Clin. Diagn. Lab. Immunol. 3:517-522.
10. Franke, C. A., T. M. Bolman, S. A. Ottum, K. F. Jones, and D. E. Hruby. 2000. Streptococcus gordonii strains resistant to fluorodeoxyuridine contain mutations in the thymidine kinase gene and are deficient in thymidine kinase activity. Antimicrob. Agents Chemother. 44:787-789.
11. Gilmore, K. S., P. Srinivas, D. R. Akins, K. L. Hatter, and M. S. Gilmore. 2003. Growth, development, and gene expression in a persistent Streptococcus gordonii biofilm. Infect. Immun. 71:4759-4766.
12. Giomarelli, B., R. Prowedi, F. Meacci, T. Maggi, D. Medaglini, G. Pozzi, T. Mori, J. B. McMahon, R. Gardella, and M. R. Boyd. 2002. The microbidde cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1. AIDS 16:1351-1356.
13. Hohwy, J., J. Reinholdt, and M. Kilian. 2001. Population dynamics of Streptococcus mitis in its natural habitat. Infect. Immun. 69:6055-6063.
14. Kilian, M., J. Reinholdt, B. Nyvad, E. V. Frandsen, and L. Mikkelsen. 1989. IgA1 proteases of oral streptococci: ecological aspects. Immunol. Investig. 18:161-170.
15. Kolenbrander, P. E., and J. London. 1993. Adhere today, here tomorrow: oral bacterial adherence. J. Bacteriol. 175:3247-3252.
16. Kononen, E., H. Jousimies-Somer, A. Bryk, T. Kilp, and M. Kilian. 2002. Establishment of streptococci in the upper respiratory tract; longitudinal changes in the mouth and nasopharynx up to 2 years of age. J. Med. Microbiol. 51:723-730.
17. Lee, S. F. 1995. Active release of bound antibody by Streptococcus mutans. Infect. Immun. 63:1940-1946.
18. Lee, S. F., S. A. Halperin, H. Wang, and A. MacArthur. 2002. Oral colonization and immune responses to Streptococcus gordonii expressing a pertussis toxin S1 fragment in mice. FEMS Microbiol. Lett. 208:175-178.
19. Lee, S. F., R. J. March, S. A. Halperin, G. Faulkner, and L. Gao. 1999. Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii. Infect. Immun. 67:1511-1516.
20. Loach, D. M., H. F. Jenkinson, and G. W. Tannock. 1994. Colonization of the murine oral cavity by Streptococcus gordonii. Infect. Immun. 62:2129-2131.
21. Lucas, V. S., D. Beighton, and G. J. Roberts. 2000. Composition of the oral streptococcal flora in healthy children. J. Dent. 28:45-50.
22. Massell, B. F., L. H. Honikman, and J. Amezcua. 1969. Rheumatic fever following streptococcal vaccination. Report of three cases. JAMA 207:1115-1119.
23. Medaglini, D., A. Ciabattini, M. R. Spinosa, T. Maggi, H. Marcotte, M. R. Oggioni, and G. Pozzi. 2001. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 19:1931-1939.
24. Medaglini, D., G. Pozzi, T. P. King, and V. A. Fischetti. 1995. Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc. Natl. Acad. Sci. USA 92:6868-6872.
25. Ogra, P. L., H. Faden, and R. C. Welliver. 2001. Vaccination strategies for mucosal immune responses. Clin. Microbiol. Rev. 14:430-445.
26. Polly, S. M., R. H. Waldman, P. High, M. K. Wittner, and A. Dorfman. 1975. Protective studies with a group A streptococcal M protein vaccine. II. Challenge of volunteers after local immunization in the upper respiratory tract. J. Infect. Dis. 131:217-224.
27. Pozzi, G., M. Contorni, M. R. Oggioni, R. Manganelli, M. Tommasino, F. Cavalieri, and V. A. Fischetti. 1992. Delivery and expression of a heterologous antigen on the surface of streptococci. Infect. Immun. 60:1902-1907.
28. Pozzi, G., R. A. Musmanno, E. A. Renzoni, M. R. Oggioni, and M. G. Cusi. 1988. Host-vector system for integration of recombinant DNA into chromosomes of transformable and nontransformable streptococci. J. Bacteriol. 170:1969-1972.
29. Pozzi, G., M. R. Oggioni, R. Manganelli, and V. A. Fischetti. 1992. Expression of M6 protein gene of Streptococcus pyogenes in Streptococcus gordonii after chromosomal integration and transcriptional fusion. Res. Microbiol. 143:449-457.
30. Rammelkamp, C. H., F. W. Denny, and L. W. Wannamaker. 1952. Studies on epidemiology of rheumatic fever in the armed services, p. 72. In L. Thomas (ed.), Rheumatic fever. A symposium. University of Minnesota. Minneapolis.
31. Ricci, S., G. Macchia, P. Ruggiero, T. Maggi, P. Bossu, L. Xu, D. Medaglini, A. Tagliabue, L. Hammarstrom, G. Pozzi, and D. Boraschi. 2003. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii. BMC Biotechnol. 3:15.
32. Ricci, S., D. Medaglini, C. M. Rush, A. Marcello, S. Peppoloni, R. Manganelli, G. Palu, and G. Pozzi. 2000. Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii. Infect. Immun. 68:760-766.
33. Sharma, A., H. Nagata, N. Hamada, H. T. Sojar, D. E. Hruby, H. K. Kuramitsu, and R. J. Genco. 1996. Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii. Appl. Environ. Microbiol. 62:3933-3938.
34. Svanberg, M., and G. Westergren. 1986. Persistence and spread of the orally-implanted bacterium Streptococcus sanguis between persons. Arch. Oral Biol. 31:1-4.
35. Tappuni, A. R., and S. J. Challacombe. 1993. Distribution and isolation frequency of eight streptococcal species in saliva from predentate and dentate children and adults. J. Dent. Res. 72:31-36.
36. Valkenburg, H. A., M. J. Haverkorn, W. R. Goslings, J. C. Lorrier, C. E. De Moor, and W. R. Maxted. 1971. Streptococcal pharyngitis in the general population. II. The attack rate of rheumatic fever and acute glomerulonephritis in patients. J. Infect. Dis. 124:348-358.